Claim(permalink)
Merck’s new drug Molnupiravir is repackaged Ivermectin
✓newschecker rating: not credible; published on 2021-10-28
✓newschecker rating: not credible; published on 2021-10-28
Factors
veracity
not credible
Political Leaning
left political leaning
Sentiment
neutral sentiment
Date published
2021-10-28
Entities
MarsCouncil of Scientific and Industrial ResearchY. S. Rajasekhara ReddySainiAntiparasiticMyalgiaEmory UniversityCiplaOnchocerciasisBiotechnologyFact-checkingRespiratory diseaseAntiviral drugPlaceboPharmaceutical industryMerck GroupMedicationIndian Council of Medical ResearchNew DelhiAll India Institutes of Medical SciencesTuberculosisRNAAustin Motor CompanyImmune systemInternetIvermectinJapanSocial mediaPandemicIndiaUnited StatesJitendra KumarNatural productKitasato UniversityRandeep GuleriaNucleoside analogueIndustrial fermentationMerck & Co.PharmacodynamicsDerivative workVexedPharmacokineticsNormal LifeNerve agentTokyo bid for the 2020 Summer Olympics